Prescription Drug Coverage in Short-Term Plans: Read This First

Prescription coverage is where short-term health insurance’s limits become most tangible: not in a policy PDF, but at the pharmacy counter, when the copay you expected turns out to be the full retail price of a brand-name drug the plan excludes. For anyone on maintenance medication, this single benefit line can decide whether STM is viable at all.
This guide explains how STM drug benefits are structured, what the pharmacy counter experience actually looks like, and the exact process for pricing your personal drug list before you buy.
The three-cap structure of STM drug benefits
STM prescription benefits are capped three ways simultaneously, and all three matter. The per-prescription cap limits what the plan pays for any single fill – commonly $150-$500. The aggregate cap limits total drug spending per benefit period – often $1,000-$5,000. The formulary limits which drugs are covered at all – usually generics, often a named generic list.
A drug can pass one filter and fail another: a $12 generic is covered but counts toward the aggregate cap; a $400 brand drug fails the per-script cap and the formulary simultaneously. Reading all three limits together is the only honest way to value the benefit.
What is typically covered vs excluded
The 2026 pattern across major carriers:
- Covered: generic antibiotics, generics for acute conditions, basic chronic generics (statins, beta blockers) on better forms – to per-script and aggregate caps
- Sometimes covered: tier-2 brands with high coinsurance; insulin on a minority of 2026 forms
- Usually excluded: brand-name maintenance drugs, specialty drugs (biologics, injectables), weight-loss and fertility drugs, drugs for excluded conditions
- Always check: the formulary document itself – carriers publish it, and it is the definitive answer
The pharmacy counter experience
Here is what happens in practice. You present the card; the pharmacist runs it; the system returns one of three answers. Covered: plan pays to the cap, you pay the remainder – a $12 generic might cost you $3; a $180 generic with a $150 cap costs you $30. Excluded: the system rejects, and the pharmacist quotes you the cash price – which, note, is often dramatically lower than the insurance-priced rate with a discount card. Not in network: the pharmacy itself is outside the plan’s pharmacy network, and the claim cannot process at all.
The third answer surprises buyers: STM plans contract pharmacy networks like medical networks, and some chains participate while others do not. Verify your pharmacy the same way you verify your doctor.
| Scenario at the counter | What happens | Your cost |
|---|---|---|
| Generic on formulary, under cap | Plan pays to cap | $0-$25 copay or remainder |
| Generic above per-script cap | Plan pays cap only | Remainder out of pocket |
| Brand/excluded drug | Claim rejected | Full cash price |
| Non-network pharmacy | Claim cannot process | Full cash price or fill elsewhere |
Pricing your exact drug list before buying
The process is mechanical and takes twenty minutes. List every prescription with dose and frequency. Get the carrier’s formulary document – demand it if the sales flow hides it. Match each drug: covered, tier, cap, and network pharmacy. For anything excluded, price the cash rate at your pharmacy (GoodRx and competitors make this easy – and note the cash price often beats the insured price anyway).
Then do the arithmetic no comparison site will do for you: monthly premium plus expected drug spend under each candidate plan. For a person on one $30 generic, STM’s drug coverage is a non-issue. For a person on two brand drugs at $300 each, the excluded-drug exposure is $7,200 annually – dwarfing any premium difference between plans.
Strategies when your drug list fails the formulary
When key drugs are excluded, four legitimate strategies exist: ask the prescriber whether therapeutic generic substitutes exist – formularies exclude categories, not always molecules; price discount cards and cash-pay pharmacy programs, which frequently undercut both insured and uninsured rates for generics; price the 90-day cash-pay programs some chains run for chronic generics; and if total exposure is large, treat the drug list as the deciding factor toward marketplace coverage, where formularies are federally standardized and brand drugs carry real caps.
The one strategy to avoid: buying STM and assuming the claim will “surely process.” It will not. The formulary rejection is systematic, not discretionary.
Frequently Asked Questions
Does short-term health insurance cover prescriptions?
Usually generics only, to a per-prescription cap ($150-$500 typical) and an aggregate term cap ($1,000-$5,000). Brand-name, specialty and many maintenance drugs are excluded on most forms.
Does STM cover insulin?
On some 2026 forms, yes, with caps; on many, no. If insulin maintenance matters to you, verify the formulary explicitly before buying – this is a make-or-break line.
What happens when a drug is not covered?
The pharmacy claim rejects and you pay the cash price – which is often lower than expected with discount programs. The exposure is uncapped and does not count toward your deductible.
Can I use discount cards with STM?
Yes – discount programs operate independently of insurance and can be combined with any plan. For excluded generics, the cash price with a discount card often beats the insured rate anyway.
Do drug costs count toward my STM deductible?
Covered drugs typically do not count toward the medical deductible – the drug benefit is its own silo with its own caps. Verify in the policy definitions.
How do I check if my medication is covered?
Get the carrier’s formulary document and match each drug, dose and cap. Or have the pharmacy run a test claim before transferring prescriptions – takes minutes and gives a definitive answer.
STM prescription benefits run through three filters – formulary, per-script cap, aggregate cap – and the second and third are where real money hides. Price your exact drug list before buying, verify your pharmacy’s network participation, and let the drug arithmetic, not the premium, decide the plan when maintenance medications are in the picture.
The 90-day fill trick for excluded generics
When a chronic generic survives the formulary but burns the per-script cap on 30-day fills, the 90-day channel changes the math: chain pharmacy 90-day programs and cash-pay subscription models price many chronic generics at $10-$30 for three months – often below what the insured copay path would cost.
The move: ask your pharmacy which of your maintenance drugs have 90-day cash rates, compare against the insured copay path including aggregate-cap burn, and split the list. It is entirely legitimate to use the insurance for some drugs and cash channels for others – the plan does not require you to run every script through it.
Prior authorization and step therapy on STM forms
Even covered drugs can carry process gates on STM forms: prior authorization (the prescriber must justify the drug before the plan pays) and step therapy (cheaper alternatives must be tried first). These gates exist on some short-term products with less administrative polish than group plans, which means longer turnaround and more faxes.
If any drug on your list is specialty-adjacent – injectables, biologics, newer molecules – assume gates exist and ask the carrier directly how long authorization takes under the specific form. A drug that is “covered” but requires three weeks of authorization processing is a different benefit than the formulary table suggests.
What to do at the counter when the claim rejects
The rejection moment at the pharmacy has a script. Ask the pharmacist three questions: what did the rejection code say, what is the cash price with a discount card, and is there a therapeutic alternative on the formulary. The code matters – “not on formulary” differs from “requires prior auth” differs from “pharmacy not in network,” and each has a different fix.
Then, if the drug matters, make one call to the plan’s pharmacy line and ask whether a formulary exception process exists – some forms have one, and prescribers can file. Everything after that is the strategies section above. What never works is paying the full cash price in silence and deciding the whole product is a scam; the counter conversation, run with the script, takes four minutes and usually finds the cheaper path.
Specialty drugs are a category decision, not a plan decision
A final framing that saves buyers from painful surprises: specialty medications – biologics, injectables, anything requiring specialty pharmacy handling – are effectively outside the STM universe entirely, regardless of carrier or form. The caps and exclusions are structural: no short-term product is designed to carry a $4,000 monthly specialty spend.
If you or a family member falls in that category, the decision was made before the shopping began: marketplace coverage with its standardized formularies and out-of-pocket maximums, employer coverage, or manufacturer patient-assistance programs operating alongside. No amount of STM comparison shopping changes it.
The bottom line
Total the article into a rule: short-term prescription coverage is adequate exactly when your list is boring – cheap generics, acute needs, nothing chronic-brand. The moment any drug on your list is expensive, brand-name, or specialty, the formulary exercise in this article stops being optional diligence and becomes the purchase decision itself. Let the drug list drive, and the plan choice makes itself.
Keep the formulary exercise as a standing document: one page, every current drug, its tier, its cap, its cash price. Update it at each renewal and each prescription change. Ten minutes of maintenance turns the pharmacy counter from a surprise into a confirmation.